Abraxis BioScience, Inc. (ABII) reported thid-quarter GAAP net loss for common shareholders of $37.7 million or $0.94 per share, compared with net loss for common shareholders of $15.1 million or $0.38 per share in the third quarter of 2008.
Adjusted net loss for common shareholders for the third quarter was $24.2 million, or $0.60 per share, versus profit of $10.5 million or $0.26 per share in the year-ago quarter.
Net revenue for the quarter grew to $96.6 million from $93.4 million in the prior year quarter.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.